Home

Baxter International (BAX)

34.51
-0.42 (-1.20%)

Baxter International is a healthcare company that focuses on developing and providing a wide range of medical products and services to enhance patient care

The company specializes in creating innovative therapies and solutions for various health conditions, including renal and hospital care. With a strong emphasis on sustainability and improving patient outcomes, Baxter manufactures essential medical devices, pharmaceuticals, and biotechnology products that support the treatment of chronic diseases and acute medical conditions. Their commitment to research and development drives advancements in healthcare technology, helping to meet the needs of healthcare professionals and patients worldwide.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close34.93
Open34.95
Bid34.30
Ask35.28
Day's Range34.00 - 35.17
52 Week Range28.33 - 44.01
Volume4,780,015
Market Cap17.25B
PE Ratio (TTM)-26.96
EPS (TTM)-1.3
Dividend & Yield1.160 (3.36%)
1 Month Average Volume5,287,486

News & Press Releases

Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at medical devices & supplies - diversified stocks, starting with Stryker (NYSESYK).
Via StockStory · February 28, 2025
“From Left For Dead To Loved Again” Stock Market (and Sentiment Results)…talkmarkets.com
Healthcare is the top-performing sector in the market, up 7.31% and outperforming the S&P 500 by 4.2x. Looks like the rumors of its death were indeed GREATLY EXAGGERATED.
Via Talk Markets · February 27, 2025
Demystifying Baxter Intl: Insights From 4 Analyst Reviewsbenzinga.com
Via Benzinga · February 26, 2025
Q4 Earnings Roundup: Baxter (NYSE:BAX) And The Rest Of The Medical Devices & Supplies - Diversified Segment
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices & supplies - diversified stocks fared in Q4, starting with Baxter (NYSEBAX).
Via StockStory · February 25, 2025
Earnings Scheduled For February 20, 2025benzinga.com
Via Benzinga · February 20, 2025
Earnings Scheduled For February 13, 2025benzinga.com
Via Benzinga · February 13, 2025
Baxter to Present at Barclays 27th Annual Global Healthcare Conference
Baxter International Inc. (NYSEBAX), a global medtech leader, will present at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2025. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time.
By Baxter International Inc. · Via Business Wire · February 25, 2025
Exploring the top movers within the S&P500 index during today's session.chartmill.com
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
Via Chartmill · February 24, 2025
Q4 Earnings Highs And Lows: Neogen (NASDAQ:NEOG) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Neogen (NASDAQNEOG) and its peers.
Via StockStory · February 24, 2025
Uncover the latest developments among S&P500 stocks in today's session.chartmill.com
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Thursday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · February 20, 2025
Baxter (NYSE:BAX) Beats Q4 Sales Targets, Stock Soars
Healthcare company Baxter International (NYSEBAX) beat Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $2.75 billion. On the other hand, next quarter’s revenue guidance of $2.58 billion was less impressive, coming in 1.4% below analysts’ estimates. Its non-GAAP profit of $1.89 per share was significantly above analysts’ consensus estimates.
Via StockStory · February 20, 2025
What's going on in today's session: S&P500 moverschartmill.com
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
Via Chartmill · February 20, 2025
Which S&P500 stocks are moving before the opening bell on Thursday?chartmill.com
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.
Via Chartmill · February 20, 2025
Baxter Q4 Earnings Beat Expectations, Issues Strong 2025 Outlookbenzinga.com
Baxter International exceeded Q4 earnings and revenue estimates, with strong pharmaceutical sales. The company issued a mixed 2025 outlook amid cost pressures.
Via Benzinga · February 20, 2025
Baxter Reports Fourth-Quarter and Full-Year 2024 Results
Baxter International Inc. (NYSEBAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2024, and provided its financial guidance for first-quarter and full-year 2025.
By Baxter International Inc. · Via Business Wire · February 20, 2025
Baxter Earnings: What To Look For From BAX
Healthcare company Baxter International (NYSEBAX) will be reporting earnings tomorrow morning. Here’s what investors should know.
Via StockStory · February 19, 2025
Baxter to Present at TD Cowen 45th Annual Health Care Conference
Baxter International Inc. (NYSEBAX), a global medtech leader, will present at the TD Cowen 45th Annual Health Care Conference on Wednesday, March 5, 2025. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 1:10 p.m. Eastern Time.
By Baxter International Inc. · Via Business Wire · February 18, 2025
Baxter to Present at Raymond James & Associates’ 46th Annual Institutional Investors Conference
Baxter International Inc. (NYSEBAX), a global medtech leader, will present at the Raymond James & Associates’ 46th Annual Institutional Investors Conference on Monday, March 3, 2025. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 1:05 p.m. Eastern Time.
By Baxter International Inc. · Via Business Wire · February 17, 2025
Baxter to Present at Citi - 2025 Medtech & Life Sciences Access Day
Baxter International Inc. (NYSEBAX), a global medtech leader, will present at the Citi - 2025 Medtech & Life Sciences Access Day on Thursday, February 27, 2025. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time.
By Baxter International Inc. · Via Business Wire · February 13, 2025
What To Expect From Baxter’s (BAX) Q4 Earnings
Healthcare company Baxter International (NYSEBAX) will be announcing earnings results tomorrow morning. Here’s what investors should know.
Via StockStory · February 12, 2025
Baxter Declares Quarterly Dividend
Baxter International Inc. (NYSEBAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on April 1, 2025, to stockholders of record as of Feb. 28, 2025. The indicated annual dividend rate is $0.68 per share of common stock.
By Baxter International Inc. · Via Business Wire · February 11, 2025
Deal Dispatch: PharmChem Forgoes Banker To Run Sale, TGI Fridays Sells 19 Restaurants For $3.1 Millionbenzinga.com
Bausch + Lomb's efforts to sell have so far been unsuccessful. Meanwhile, KKR is aggressively pursuing a deal for Fuji Soft.
Via Benzinga · February 7, 2025
Baxter Announces CEO Retirement and Appointment of COO
Baxter International Inc. (NYSEBAX), a global medtech leader, today announced that José (Joe) E. Almeida, chair, president and chief executive officer (CEO), will retire from his executive roles with the company, effective immediately. He will serve in an advisory capacity through Oct. 31, 2025.
By Baxter International Inc. · Via Business Wire · February 3, 2025
Baxter Kidney Care is Now Vantive, A New Standalone Vital Organ Therapy Company
Vantive builds on a 70-year legacy of kidney care leadership and innovation, with a singular focus on empowering patients and care teams with more flexible, collaborative and accessible care options
By Vantive · Via GlobeNewswire · February 3, 2025
10 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · January 27, 2025